Breast Cancer Grading and Staging
Staging and grading are ways in which healthcare professionals describe the size of your breast cancer, whether and how far it has spread, and how fast it may grow. Grading is Assess by evaluating acinar formation, nuclear size/pleomorphism and mitotic activity. An attempt should be made to grade the pre-operative core biopsy as there is acceptable concordance with excision grade.
Grading:
Grade 1 – the cancer cells look small and uniform like normal cells, and are usually slow-growing compared to other grades of breast cancer
Grade 2 – the cancer cells are slightly bigger than normal cells, varying in shape and are growing faster than normal cells
Grade 3 – the cancer cells look different to normal cells, and are usually faster-growing than normal cells
Staging: Staging is used to assess the size of a tumour, whether it has spread and how far it has spread. Understanding the stage of the cancer helps doctors to predict the likely outcome and design a treatment plan for individual patients.
Stage 1: Usually means that a cancer is relatively small and contained within the breast.
Stage 2 usually means the cancer has not started to spread into surrounding tissue but the tumour is larger than in Stage 1. Sometimes Stage 2 means that cancer cells have spread into lymph nodes close to the tumour.
Stage 3 usually means the cancer is larger. It may have started to spread into surrounding tissues and there are cancer cells in the lymph nodes in the area.
Stage 4 means the cancer has spread from where it started to another body organ. This is also called secondary or metastatic cancer.
Related Conference of Breast Cancer Grading and Staging
9th International Conference on Gynecology and Obstetrics Pathology
Breast Cancer Grading and Staging Conference Speakers
Recommended Sessions
- Breast Cancer Grading and Staging
- Breast Cancer Pathology
- Breast Cancer Pathology in Pregnancy
- Breast Cancer Prevention
- Breast Cancer: Challenges, Breakthroughs
- Breast Diseases
- Breast Implants
- Breast Pathology Treatment and Drugs
- Case study and Case Reports
- Male Breast Cancer
- Nursing and Palliative care rehabilitation
- Recurrent Breast Cancer
- Screening, Monitoring and Diagnosis
- Women’s Health and Fitness
- Breast Cancer and Genetics
- Breast Cancer Surgery
- Breast Pathology and Immunohistochemistry
- Latest Advances and Innovative Therapeutic Approaches
- Special Types of Breast Cancer
Related Journals
Are you interested in
- Adolescent Gynecology - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Advances in Diagnostic Pathology - Euro Pathology 2025 (UK)
- Anatomical Pathology - Pathology 2025 (UK)
- Breast Cancer and Genetics - Breast Pathology 2025 (UK)
- Breast Cancer Grading and Staging - Breast Pathology 2025 (UK)
- Breast Cancer Pathology - Breast Pathology 2025 (UK)
- Breast Cancer Pathology in Pregnancy - Breast Pathology 2025 (UK)
- Breast Cancer Prevention - Breast Pathology 2025 (UK)
- Breast Cancer Surgery - Breast Pathology 2025 (UK)
- Breast Cancer: Challenges, Breakthroughs - Breast Pathology 2025 (UK)
- Breast Diseases - Breast Pathology 2025 (UK)
- Breast Health and Diseases - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Breast Implants - Breast Pathology 2025 (UK)
- Breast Pathology - Pathology 2025 (UK)
- Breast Pathology and Immunohistochemistry - Breast Pathology 2025 (UK)
- Breast Pathology Treatment and Drugs - Breast Pathology 2025 (UK)
- Cancer Pathology - Pathology 2025 (UK)
- Cancer Pathology - Euro Pathology 2025 (UK)
- Cardiovascular Pathology - Euro Pathology 2025 (UK)
- Case study and Case Reports - Breast Pathology 2025 (UK)
- Clinical and Surgical Pathology - Euro Pathology 2025 (UK)
- Clinical Pathology - Pathology 2025 (UK)
- Contraception and Family Planning - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Cytopathology and Histopathology - Pathology 2025 (UK)
- Dermatopathology - Euro Pathology 2025 (UK)
- Dermatopathology - Pathology 2025 (UK)
- Digital Pathology and Artificial Intelligence - Euro Pathology 2025 (UK)
- Digital Pathology and e-Pathology - Pathology 2025 (UK)
- Endometriosis and Fibroids - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Experimental Pathology - Euro Pathology 2025 (UK)
- Forensic Pathology - Euro Pathology 2025 (UK)
- Gastrointestinal and Liver Pathology - Pathology 2025 (UK)
- Gastrointestinal and Liver Pathology - Euro Pathology 2025 (UK)
- Genetics in Gynecology and Obstetrics - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Gynecologic Oncology - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Gynecologic Pathology - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Gynecologic Surgery - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Hematopathology - Pathology 2025 (UK)
- Hematopathology - Euro Pathology 2025 (UK)
- Imaging in Gynecology and Obstetrics - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Immunopathology - Euro Pathology 2025 (UK)
- Infectious Diseases in Obstetrics and Gynecology - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Latest Advances and Innovative Therapeutic Approaches - Breast Pathology 2025 (UK)
- Male Breast Cancer - Breast Pathology 2025 (UK)
- Maternal-Fetal Medicine - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Menopause and Hormone Replacement Therapy - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Microbial Pathology - Pathology 2025 (UK)
- Minimally Invasive Gynecologic Surgery - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Molecular Pathology - Pathology 2025 (UK)
- Molecular Pathology and Genomic Medicine - Euro Pathology 2025 (UK)
- Neuropathology - Euro Pathology 2025 (UK)
- Nursing and Palliative care rehabilitation - Breast Pathology 2025 (UK)
- Obstetric Anesthesia - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Oral and Maxillofacial Pathology - Pathology 2025 (UK)
- Pathology Education and Training - Euro Pathology 2025 (UK)
- Pathology in Personalized Medicine - Euro Pathology 2025 (UK)
- Pathology of Genetic and Rare Diseases - Euro Pathology 2025 (UK)
- Pathology of Infectious Diseases - Euro Pathology 2025 (UK)
- Patient Safety and Quality in Gynecology and Obstetrics - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Pediatric Pathology - Euro Pathology 2025 (UK)
- Perinatal and Neonatal Care - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Prenatal Diagnosis and Screening - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Recurrent Breast Cancer - Breast Pathology 2025 (UK)
- Renal Pathology - Euro Pathology 2025 (UK)
- Renal Pathology - Pathology 2025 (UK)
- Reproductive and Gynecological Pathology - Euro Pathology 2025 (UK)
- Reproductive Endocrinology and Infertility - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Screening, Monitoring and Diagnosis - Breast Pathology 2025 (UK)
- Sexual and Reproductive Health - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Special Types of Breast Cancer - Breast Pathology 2025 (UK)
- Surgical Pathology - Pathology 2025 (UK)
- Urogynecology and Pelvic Floor Disorders - GYNECOLOGY AND OBSTETRICS 2025 (Netherlands)
- Veterinary Pathology - Pathology 2025 (UK)
- Women’s Health and Fitness - Breast Pathology 2025 (UK)